Olmesartan Clinical Trial in Okinawan Patients Under Okinawa Dialysis Study

Phase 4

Active, not recruiting

• Conditions: chronic hemodialysis patients (3/week); Renal and Urogenital - Kidney disease; Cardiovascular - Hypertension; Hypertension

• Registration Number: ACTRN12609000838213
• Lead Sponsor: Kinitoshi Iseki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-01-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 462

Inclusion Criteria

1. Chronic hemodialysis patients (3/week),

2. High predialysis systolic blood pressure >140mmHg or

High predialysis diastolic blood pressure >90mmHg, or Both

Exclusion Criteria

1.Recent onset (within one month) of cardiovascular disease and congestive heart failure

2.Severe hypertension (high predialysis systolic blood pressure >200mmHg or high predialysis diastolic blood pressure >100mmHg

3.Patient on angiotensin converting enzyme inhibitors (ACEI) or other angiotensin receptor blockades (ARB), (washoout at least one month)

Study & Design

• Study Type: Interventional
• Study Design: Not specified